Nurix Therapeutics (NRIX) Insider Trading & Ownership $13.59 +0.40 (+3.03%) Closing price 04:00 PM EasternExtended Trading$13.42 -0.16 (-1.21%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Nurix Therapeutics (NASDAQ:NRIX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$2.22 M Get NRIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NRIX Insider Buying and Selling by Quarter Remove Ads Nurix Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/3/2025Houte Hans VanCFOSell5,825$14.49$84,404.25 1/30/2025Gwenn HansenInsiderSell3,690$19.85$73,246.50 1/30/2025Houte Hans VanCFOSell2,811$19.85$55,798.35 11/1/2024Houte Hans VanCFOSell3,546$24.28$86,096.88 10/30/2024Gwenn HansenInsiderSell3,437$24.30$83,519.10 10/30/2024Houte Hans VanCFOSell2,368$24.30$57,542.40 10/14/2024Christine RingInsiderSell3,290$25.00$82,250.00 10/1/2024Christine RingInsiderSell5,760$22.23$128,044.80 9/3/2024Christine RingInsiderSell9,050$24.94$225,707.00 8/26/2024Christine RingInsiderSell9,870$25.01$246,848.70 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/26/2024Houte Hans VanCFOSell20,000$25.22$504,400.00 8/1/2024Christine RingInsiderSell5,760$21.43$123,436.80 8/1/2024Houte Hans VanCFOSell3,477$21.45$74,581.65 7/30/2024Gwenn HansenInsiderSell3,408$20.67$70,443.36 7/30/2024Houte Hans VanCFOSell2,490$20.67$51,468.30 7/1/2024Christine RingInsiderSell5,760$20.81$119,865.60 6/12/2024Christine RingInsiderSell1,900$17.01$32,319.00 6/5/2024Christine RingInsiderSell400$17.00$6,800.00 6/3/2024Christine RingInsiderSell1,596$17.01$27,147.96 5/2/2024Houte Hans VanCFOSell3,499$12.83$44,892.17 4/30/2024Gwenn HansenInsiderSell2,007$12.04$24,164.28 4/30/2024Houte Hans VanCFOSell1,387$12.04$16,699.48 (Data available from 1/1/2013 forward) NRIX Insider Trading Activity - Frequently Asked Questions Who is on Nurix Therapeutics's Insider Roster? The list of insiders at Nurix Therapeutics includes Christine Ring, Gwenn Hansen, Houte Hans Van, and Stefani Wolff. Learn more on insiders at NRIX. What percentage of Nurix Therapeutics stock is owned by insiders? 7.20% of Nurix Therapeutics stock is owned by insiders. Learn more on NRIX's insider holdings. Which Nurix Therapeutics insiders have been selling company stock? The following insiders have sold NRIX shares in the last 24 months: Christine Ring ($1,019,267.42), Gwenn Hansen ($299,426.18), Houte Hans Van ($1,191,304.74), and Stefani Wolff ($3,378.96). How much insider selling is happening at Nurix Therapeutics? Insiders have sold a total of 132,796 Nurix Therapeutics shares in the last 24 months for a total of $2,513,377.30 sold. Nurix Therapeutics Key ExecutivesDr. Arthur T. Sands M.D. (Age 62)Ph.D., CEO, President & Director Compensation: $986.32kMr. Johannes Van Houte (Age 58)Chief Financial Officer Compensation: $681.98kDr. Gwenn M. Hansen Ph.D. (Age 53)Chief Scientific Officer Compensation: $702.75kDr. John Kuriyan Ph.D.Founder & Member of Scientific Advisory BoardMr. Michael Rapé Ph.D.Founder & Member of Scientific Advisory BoardDr. Arthur Weiss M.D.Ph.D., Founder & Member of Scientific Advisory BoardRita KwongSenior Accounting ManagerDr. Christine Ring J.D. (Age 59)Ph.D., Chief Legal Officer, Secretary & Chief Compliance Officer Compensation: $595.83kMr. Eric C. Schlezinger J.D. (Age 57)Chief People Officer Dr. Jason Kantor Ph.D.Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies OGN Insider Trades ACLX Insider Trades ADMA Insider Trades ZLAB Insider Trades SWTX Insider Trades RNA Insider Trades RARE Insider Trades IMVT Insider Trades PTGX Insider Trades SRRK Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles SentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are Buying This page (NASDAQ:NRIX) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredOur #1 Defense Stock for MarchChina just deepened its military alliance with America's enemies in the Middle East... By conducting joint ...Behind the Markets | SponsoredElon’s desperate gambleWarning: "DOGE Collapse" Imminent After months of cost-cutting, controversy, and media buzz, DOGE is on the...Altimetry | SponsoredTrump’s new tariffs could break China’s grip on manufacturingLooming trade wars have China scrambling… Over 90% of global corporate executives said they are shutting do...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
